Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer
Authors:
- 4 June 2013
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 36 (7) , 947-953
Abstract
Background: The purpose of this study was to investigate whether the pretreatment total and differential leukocyte counts can predict the prognosis of patients with oral cavity cancer.Methods: In a retrospective analysis of patients treated between 2004 and 2011, medical records of 202 patients with oral cavity cancer were evaluated.Results: Patients with oral cavity cancer, the peripheral total white blood cell (WBC) count, monocyte, and neutrophil counts and neutrophil lymphocyte ratio increased with the advancement of clinical stage. In contrast, the lymphocyte count decreased. Further, total WBC, monocyte, and neutrophil counts were increased in those with pathologic stage T4 and poor tumor differentiation, and the monocyte count was also increased in those with lymph node metastasis. Moreover, the pretreatment circulating monocyte count was an independent prognostic factor for cancer‐specific survival.Conclusion: A higher pretreatment circulating monocyte count can be considered as a useful prognostic marker in patients with oral cavity cancer. © 2014 Wiley Periodicals, Inc. Head Neck 36: 947–953, 2014Keywords
This publication has 40 references indexed in Scilit:
- A Novel Cellular Model to Study Angiotensin II AT2 Receptor Function in Breast Cancer CellsInternational Journal of Peptides, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resectionWorld Journal of Surgical Oncology, 2010
- Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable CancerFuture Oncology, 2009
- Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancerJournal of Cancer Research and Clinical Oncology, 2009
- Induction of proinflammatory response in prostate cancer epithelial cells by activated macrophagesCancer Letters, 2009
- Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic CellsCancer Cell, 2008
- Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancerBritish Journal of Cancer, 2007
- An immune origin of type 2 diabetes?Diabetologia, 2005
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004